Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease (Q35594747)
scientific article published on July 2002
Language:
(P31) (Q13442814)
(P304) 30-36
(P407) (Q1860)
(P433) 1
(P478) 51
(P577) Monday, July 1, 2002
(P921) (Q269829)
(Q1472)
(P1433) (Q5621669)
(P1476) "Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease" (language: en)
(P2093) B R Yacyshyn
W Y Chey
J Goff
B Salzberg
R Baerg
A L Buchman
J Tami
R Yu
E Gibiansky
W R Shanahan
ISIS 2302-CS9 Investigators
(P2860) (Q29041098)
(Q41753946)
(Q40625955)
(Q35357996)
(Q33874988)
(Q38321176)
(Q33657678)
(Q33635629)
(Q38334084)
(Q48019594)
(Q28262496)
(Q46550655)
(Q37355206)
(Q42516217)
(Q38304921)
(Q34291470)
(Q29547181)
(Q34117998)
(Q28299810)
(Q48328947)
(Q41664990)
(Q43582800)
(Q41753038)
(Q46767395)
(Q52868127)
(Q46725691)
(Q57962449)
(Q71654270)
(Q73343781)
(Q73567824)
(Q68322277)
(Q72227685)
(Q71650239)
(Q72727674)
(Q72813025)
(Q59120846)
(Q71668377)
(Q72646581)
(Q71767085)
(Q74074833)
other details
description scientific article published on July 2002

External Links